on ABIVAX (EPA:ABVX)
ABIVAX: Details on Share Capital and Voting Rights as of February 28, 2026
On March 27, 2026, ABIVAX, listed on Euronext Paris under the ticker symbol ABVX, announced the composition of its share capital and the total number of voting rights. The share capital amounts to €792,028.88, divided into 79,185,160 shares. The total number of theoretical and exercisable voting rights is 81,538,485. These figures are calculated in accordance with the required legal and regulatory provisions, including shares without voting rights.
By taking this data into account, the company ensures transparency regarding its capital structure. This information is crucial for shareholders wishing to assess their stake in the company and to monitor any potential threshold crossings.
R. E.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all ABIVAX news